These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23468831)

  • 1. Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.
    Prokosch V; Schallenberg M; Thanos S
    PLoS One; 2013; 8(2):e49730. PubMed ID: 23468831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorzolamide and timolol saves retinal ganglion cells in glaucomatous adult rats.
    Sarup V; McEwan GC; Thompson C; Patil KA; Sharma SC
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):454-62. PubMed ID: 16386087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model.
    Schallenberg M; Prokosch V; Thanos S
    PLoS One; 2012; 7(7):e33593. PubMed ID: 22792152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure lowering, change of antiapoptotic molecule expression, and neuroretinal changes by dorzolamide 2%/timolol 0.5% combination in a chronic ocular hypertension rat model.
    Park HY; Lee NY; Kim JH; Park CK
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):563-71. PubMed ID: 19049297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
    Wang RF; Serle JB; Gagliuso DJ; Podos SM
    J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure.
    Díaz F; Villena A; Moreno M; Vidal L; Parrado C; García-Campos J; de Vargas IP
    Histol Histopathol; 2005 Oct; 20(4):1077-84. PubMed ID: 16136490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.
    Tezel G; Yang X; Cai J
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3177-87. PubMed ID: 16123417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model.
    Kalogerou M; Kolovos P; Prokopiou E; Papagregoriou G; Deltas C; Malas S; Georgiou T
    Exp Eye Res; 2018 Feb; 167():128-139. PubMed ID: 29258748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
    Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE; MacKay EO; Gelatt KN
    Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
    Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
    Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
    Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
    Coleman AL; Lerner F; Bernstein P; Whitcup SM
    Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.